Literature DB >> 7777111

Liposoluble vitamins E and A in human renal cortex and renal cell carcinomas.

N V Nikiforova1, V I Kirpatovsky, A F Darenkov, A M Chumakov, E A Sevrukov, S P Darenkov.   

Abstract

Vitamin E was quantified in renal cell carcinomas (RCC) and in 'intact' renal cortex, obtained from 31 patients subjected either to unilateral nephrectomy or to partial resection of the only kidney. Histologically, 14 tumors consisted predominantly of clear cells (group 1) and 17 of other cell types (group 2). In both groups, a significant increase in vitamin E concentration, as compared to the 'intact' cortex, was observed: 167.8 +/- 27.9 and 68.2 +/- 15.2 micrograms/g wet tissue weight (mean +/- SEM) for groups 1 and 2, respectively, versus 10.1 +/- 0.53 micrograms/g wet tissue weight for the cortex. Although the total lipid content was also increased in tumors (especially in group 1), the vitamin E concentration in tumor tissue, calculated per milligram of total lipids, proved to be much higher in both groups than in 'intact' cortex. A significant positive correlation was observed between vitamin E and total lipid content in group 1 and 2 carcinomas. It was also found that vitamin E accumulation in RCC is unlikely to be attributed to an enhanced lipid deposit in the tumor cells. Thus, in 8 tumors of group 2 the vitamin E levels were markedly enhanced although these tumors did not differ from the cortex in total lipid concentrations. Vitamin A content determined in 17 carcinomas, when calculated per milligram of total lipids, was the same as in 'intact' cortex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777111     DOI: 10.1159/000188518

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Metabolic profiling reveals key metabolic features of renal cell carcinoma.

Authors:  Gareth Catchpole; Alexander Platzer; Cornelia Weikert; Carsten Kempkensteffen; Manfred Johannsen; Hans Krause; Klaus Jung; Kurt Miller; Lothar Willmitzer; Joachim Selbig; Steffen Weikert
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

2.  UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.

Authors:  Zhan Wang; Xiaoyan Liu; Xiang Liu; Haidan Sun; Zhengguang Guo; Guoyang Zheng; Yushi Zhang; Wei Sun
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

3.  Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Authors:  Angelika Tölle; Monika Jung; Michael Lein; Manfred Johannsen; Kurt Miller; Holger Moch; Klaus Jung; Glen Kristiansen
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.